Chris H. Takimoto - May 13, 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Medical Officer
Signature
/s/ Misbah Tahir, by power of attorney
Stock symbol
IGMS
Transactions as of
May 13, 2022
Transactions value $
$10,214
Form type
4
Date filed
5/17/2022, 07:00 PM
Previous filing
Mar 17, 2022
Next filing
May 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $10.2K +825 +2.23% $12.38 37.8K May 13, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).